InvivoSciences announced today it is the recipient of a $700,000 SBIR grant.

According to a release, the money from the National Institute of Aging will help InvivoSciences collaborate with the Torrey Pines Institute of Molecular Studies on identification of novel therapeutic options for cardiac fibrosis.

“Our novel drug screening system using human grown wound tissues screens a chemical library that is systematically designed to identify drug candidates running fewer tests,” InvivoSciences CEO and President Ayla Annac said. “Our collaboration aims to serve this unmet need by utilizing and unifying our innovative capabilities and resources to achieve end results of making differences in patients aged 65 and older with cardiac fibrosis in the United States and worldwide.”

The project will use InvivoSciences’ engineered tissue-based screening system with TPIMS’ compound library to find compounds that can change the disease model phenotype.